Community-reported Fabrazyme side effects:
Add Your Side Effect to the Community Database
Help Community - Describe Your Fabrazyme Side Effect
Have You dealt with a Fabrazyme side effect? Share your experience
Review Fabrazyme Safety Reports submitted to FDA
Total Fabrazyme reports: 435.Fabrazyme FDA safety alerts: No.
Reported deaths: 90 Reported hospitalizations: 289.
Take Fabrazyme Side Effects Survey, Discuss Fabrazyme with others
FDA Reported Fabrazyme Side Effects: infusion related reaction, condition aggravated, renal transplant, chills, renal failure chronic, pain in extremity, myocardial infarction, dyspnoea, dyspnoea exertional, nausea, oedema peripheral.
More About Fabrazyme.
If you have questions about Fabrazyme, you can ask a Health Expert or Ask Patient Community about Fabrazyme.
Featured polls
- What did you do to overcome side effect?
- Did you and your doctor discuss the risks and side effects of the drug, or not?
- When you are buying over the counter medication for the first time how often, if ever, do you look for warnings about possible side effects?
- When you have a prescription filled, how often does the pharmacist tell you about side effects you may experience?
- Have you, personally, ever attempted to lose weight in your lifetime, or not?
- How easy or hard do you think it is for most people who are very overweight to lose weight?
Showing 1-100 of 435 Next >
Fabrazyme Side Effects Report #5579020-XPhysician from UNITED STATES reported FABRAZYME problem on Dec 17, 2007. Female patient, 59 years of age, weighting 187.4 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: breast cancer recurrent. FABRAZYME dosage: 85 MG, Q2W, INTRAVENOUS. Patient recovered.
Fabrazyme Side Effects Report #5579048-X
FABRAZYME problem was reported by a Physician from UNITED STATES on Dec 13, 2007. Female patient, weighting 13.89 lb, was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: abscess neck, branchial cyst, cellulitis, dermatitis, infected cyst, wound infection staphylococcal. FABRAZYME dosage: unknown. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5579296-9
Physician from UNITED STATES reported FABRAZYME problem on Dec 17, 2007. Female patient was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, asthma, infusion related reaction, pain in extremity, proteinuria, pyrexia. FABRAZYME dosage: 55 MG, Q2W, INTRAVENOUS. Patient recovered.
Fabrazyme Side Effects Report #5579301-X
FABRAZYME problem was reported by a Physician from UNITED STATES on Dec 19, 2007. Male patient, 52 years of age, weighting 158.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: ear infection, hearing impaired, meningitis bacterial. FABRAZYME dosage: 75 MG, Q2W, INTRAVENOUS. Patient was hospitalized and became disabled. Patient recovered.
Fabrazyme Side Effects Report #5580776-0
Pharmacist from GERMANY reported FABRAZYME problem on Dec 13, 2007. Male patient was diagnosed with fabry's disease and was treated with FABRAZYME. FABRAZYME dosage: unknown. Patient died on 01/01/2007.
Fabrazyme Side Effects Report #5506324-9
FABRAZYME problem was reported by a Physician from JAPAN on Oct 19, 2007. Female patient was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, pancreatitis. FABRAZYME dosage: 50 MG Q2WKS IV. Patient died on 10/19/2007.
Fabrazyme Side Effects Report #5507200-8
Consumer or non-health professional from UNITED STATES reported FABRAZYME problem on Oct 23, 2007. Female patient was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: intervertebral disc operation. FABRAZYME dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5507317-8
FABRAZYME problem was reported by a Physician from BRAZIL on Oct 22, 2007. Male patient, 55 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. FABRAZYME dosage: unknown. Patient died on 10/19/2007.
Fabrazyme Side Effects Report #5507319-1
Physician from MEXICO reported FABRAZYME problem on Oct 24, 2007. Female patient was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: gastrointestinal haemorrhage, haematemesis, hypovolaemic shock, nausea, vomiting. FABRAZYME dosage: 70 MG Q2WKS IV. Patient died on 10/21/2007.
Fabrazyme Side Effects Report #5510194-2
FABRAZYME problem was reported by a Physician from FINLAND on Oct 24, 2007. Female patient, 68 years of age, weighting 205.0 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: decubitus ulcer, erysipelas, intestinal obstruction, oedema peripheral, pleural effusion. FABRAZYME dosage: 105 MG Q2WKS IV. Patient was hospitalized. Patient died on 08/25/2007.
Fabrazyme Side Effects Report #5517733-6
Physician from UNITED STATES reported FABRAZYME problem on Nov 01, 2007. Male patient, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. FABRAZYME dosage: 70 MG Q2WKS IV. Patient died on 01/01/2007.
Fabrazyme Side Effects Report #5517734-8
FABRAZYME problem was reported by a Health Professional from UNITED STATES on Nov 01, 2007. Male patient, 62 years of age, was diagnosed with fabry's disease, polyuria and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: atelectasis, blood potassium decreased, cardiac failure congestive, cardiomyopathy, disease progression, hypotension, implantable defibrillator malfunction, lethargy. FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with LASIX, COUMADIN, COREG, ZANTAC, LORTAB. Patient was hospitalized. Patient died on 09/23/2007.
Fabrazyme Side Effects Report #5517789-0
Physician from UNITED STATES reported FABRAZYME problem on Oct 29, 2007. Male patient, weighting 150.0 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cardiac valve disease, cerebral disorder, cerebrovascular accident, coronary artery occlusion, intracranial aneurysm, procedural complication. FABRAZYME dosage: unknown. During the same period patient was treated with SIMVASTATIN, FLONASE, LISINOPRIL, COUMADIN. Patient recovered.
Fabrazyme Side Effects Report #5517993-1
FABRAZYME problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 31, 2007. Male patient, 52 years of age, weighting 158.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: meningitis bacterial. FABRAZYME dosage: 75 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5517994-3
Consumer or non-health professional from UNITED STATES reported FABRAZYME problem on Oct 30, 2007. Male patient, 55 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: ill-defined disorder. FABRAZYME dosage: 50 MG QWK IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5517995-5
FABRAZYME problem was reported by a Physician from UNITED STATES on Nov 05, 2007. Female patient, 59 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: intervertebral disc operation. FABRAZYME dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5518425-X
Physician from JAPAN reported FABRAZYME problem on Oct 31, 2007. Male patient, 76 years of age, weighting 99.21 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cardiac failure. FABRAZYME dosage: 45 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5521066-1
FABRAZYME problem was reported by a Physician from UNITED STATES on Nov 03, 2007. Female patient, 56 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood creatine phosphokinase mb increased, blood pressure decreased, blood thyroid stimulating hormone increased, bradycardia, heart injury, heart rate irregular, treatment failure. FABRAZYME dosage: unknown. During the same period patient was treated with SYNTHROID. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5521558-5
Consumer or non-health professional from COSTA RICA reported FABRAZYME problem on Nov 06, 2007. Male patient, 70 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: accident, pelvic fracture. FABRAZYME dosage: 1 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5522034-6
FABRAZYME problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2007. Male patient, 25 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: osteomyelitis. FABRAZYME dosage: 1 MG/KG Q2WKS; IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5525739-6
Physician from JAPAN reported FABRAZYME problem on Nov 09, 2007. Male patient, 76 years of age, weighting 99.21 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cardiac failure, ill-defined disorder. FABRAZYME dosage: 45 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5525740-2
FABRAZYME problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 12, 2007. Female patient, 65 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. FABRAZYME dosage: 105 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5527184-6
Physician from UNITED STATES reported FABRAZYME problem on Nov 13, 2007. Female patient, 56 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood creatine phosphokinase mb increased, blood pressure decreased, blood thyroid stimulating hormone increased, bradycardia, heart injury, heart rate irregular, troponin increased. FABRAZYME dosage: unknown. During the same period patient was treated with SYNTHROID, AMIODARONE, LIPITOR, COZAAR, WARFARIN. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5527233-5
FABRAZYME problem was reported by a Health Professional from UNITED STATES on Nov 14, 2007. Male patient, child 9 years of age, weighting 48.94 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: catheter site pain, erythema, hypoaesthesia, infusion related reaction, lip swelling, paraesthesia, pruritus, rash, swollen tongue. FABRAZYME dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with TYLENOL, BENADRYL. Patient recovered.
Fabrazyme Side Effects Report #5527234-7
Health Professional from UNITED STATES reported FABRAZYME problem on Nov 15, 2007. Male patient, 34 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: overdose. FABRAZYME dosage: unknown. During the same period patient was treated with BENADRYL, ZOFRAN, DEMEROL. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5528222-7
FABRAZYME problem was reported by a Physician from UNITED STATES on Nov 13, 2007. Male patient, 52 years of age, weighting 158.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: meningitis bacterial. FABRAZYME dosage: 75 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5530374-X
Physician from COLOMBIA reported FABRAZYME problem on Nov 16, 2007. Male patient, 17 years of age, weighting 83.78 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: catheter site infection, peritonitis. FABRAZYME dosage: 35 MG Q2WKS IV. During the same period patient was treated with PRAZOSINE, METOPROLOL, AMLODIPINE, ENALAPRIL, LOVASTATIN. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5533872-8
FABRAZYME problem was reported by a Physician from JAPAN on Nov 16, 2007. Male patient, 55 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, aspartate aminotransferase increased, conduction disorder, disease progression, hepatic function abnormal. FABRAZYME dosage: 50 MG Q2WKS IV. During the same period patient was treated with BETA BLOCKER. Patient died on 11/14/2007.
Fabrazyme Side Effects Report #5534171-0
Health Professional from UNITED STATES reported FABRAZYME problem on Nov 30, 2007. Male patient was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: hospitalisation. FABRAZYME dosage: 105 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5477470-3
FABRAZYME problem was reported by a Pharmacist from UNITED KINGDOM on Sept 17, 2007. Male patient was diagnosed with fabry's disease, diarrhoea and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: hypersensitivity. FABRAZYME dosage: 35 MG IV. During the same period patient was treated with LOPERAMIDE, ASPIRIN, CARBAMAZEPINE, SOTALOL HYDROCHLORIDE, PROCYCLIDINE HYDROCHLORIDE, LANSOPRASOLE, NICORANDIL. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5477785-9
Physician from JAPAN reported FABRAZYME problem on Sept 18, 2007. Female patient, 48 years of age, weighting 114.6 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cardiac failure, condition aggravated, ventricular extrasystoles. FABRAZYME dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, CARVEDILOL. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5477786-0
FABRAZYME problem was reported by a Physician from JAPAN on Sept 18, 2007. Female patient, 48 years of age, weighting 114.6 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cardiac failure, condition aggravated, disease progression, ventricular extrasystoles. FABRAZYME dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, CARVEDILOL. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5477787-2
Physician from FRANCE reported FABRAZYME problem on Sept 17, 2007. Male patient, 55 years of age, weighting 149.9 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: brain stem ischaemia, extravasation, poor venous access. FABRAZYME dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with CELLCEPT, NEORAL, UNALFA, VASTIN, ZYLORIC, FONZYLANE, ALDACTONE. Patient died on 05/26/2007.
Fabrazyme Side Effects Report #5477788-4
FABRAZYME problem was reported by a Physician from JAPAN on Sept 18, 2007. Female patient, 48 years of age, weighting 114.6 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cardiac failure, condition aggravated, ventricular extrasystoles. FABRAZYME dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, CARVEDILOL. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5479831-5
Consumer or non-health professional from UNITED STATES reported FABRAZYME problem on Sept 21, 2007. Male patient, 51 years of age, weighting 174.8 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cerebral haemorrhage, cerebrovascular accident. FABRAZYME dosage: 105 MG Q2WKS IV. Patient was hospitalized. Patient died on 09/26/2007.
Fabrazyme Side Effects Report #5480917-X
FABRAZYME problem was reported by a Health Professional from UNITED KINGDOM on Sept 21, 2007. Female patient was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cerebellar atrophy, spinal cord infarction. FABRAZYME dosage: 1 MG/KG Q2WKS IV. Patient recovered.
Fabrazyme Side Effects Report #5481158-2
Physician from UNITED STATES reported FABRAZYME problem on Sept 20, 2007. Male patient, 34 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: swollen tongue. FABRAZYME dosage: 55 MG Q2WKS IV. Patient recovered.
Fabrazyme Side Effects Report #5482025-0
FABRAZYME problem was reported by a Physician from UNITED STATES on Sept 21, 2007. Male patient, 62 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, cardiac failure congestive, device breakage, implantable defibrillator malfunction, pneumonia, ventricular tachycardia. FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with LASIX, COUMADIN, COREG, ZANTAC, LORTAB. Patient was hospitalized. Patient died on 09/23/2007.
Fabrazyme Side Effects Report #5482026-2
Consumer or non-health professional from UNITED STATES reported FABRAZYME problem on Sept 25, 2007. Male patient, 65 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: transient ischaemic attack. FABRAZYME dosage: 1 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5483870-8
FABRAZYME problem was reported by a Physician from NETHERLANDS on Sept 25, 2007. Male patient, 51 years of age, weighting 176.4 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: disease progression, gait disturbance, nuclear magnetic resonance imaging brain abnormal, oesophagitis, polyneuropathy, sensorimotor disorder, treatment failure, walking aid user. FABRAZYME dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with METOPROLOL, MONOCEDOCARD, NEXIUM, LIPITOR, LYRICA, ASPIRIN AND DIPYRIDAMOLE. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5483898-8
Physician from JAPAN reported FABRAZYME problem on Sept 26, 2007. Male patient, 41 years of age, weighting 105.8 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: asthenia, cerebral infarction, delirium, dizziness, dysstasia, psychotic disorder. FABRAZYME dosage: 50 MG Q2WKS; IV. During the same period patient was treated with CELESTAMINE, DICLOFENAC, LACTOMIN, SEVELAMER HYDROCHLORIDE, CARBAMAZEPINE. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5483899-X
FABRAZYME problem was reported by a Physician from JAPAN on Sept 26, 2007. Male patient, 41 years of age, weighting 105.8 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: alanine aminotransferase increased, anorexia, aspartate aminotransferase increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, cachexia, cardio-respiratory arrest, cerebral ischaemia. FABRAZYME dosage: 50 MG Q2WKS; IV. During the same period patient was treated with CELESTAMINE, DICLOFENAC, LACTOMIN, SEVELAMER HYDROCHLORIDE, CARBAMAZEPINE. Patient was hospitalized. Patient died on 10/11/2004.
Fabrazyme Side Effects Report #5484278-1
Health Professional from UNITED STATES reported FABRAZYME problem on Oct 02, 2007. Male patient, 34 years of age, weighting 112.0 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: blood pressure fluctuation, infusion related reaction, swollen tongue. FABRAZYME dosage: 55 MG Q2WKS IV. During the same period patient was treated with TYLENOL, CLARITIN. Patient recovered.
Fabrazyme Side Effects Report #5484496-2
FABRAZYME problem was reported by a Physician from JAPAN on Sept 26, 2007. Male patient, 64 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: arrhythmia, cardiac arrest, myocardial infarction. FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with DICLOFENAC, BETAMETHASONE, WARFARIN POTASSIUM, ENALAPRIL MALEATE, PRECIPITATED CALCIUM CARBONATE, MECOBALAMIN, ALFACALCIDOL. Patient died on 01/08/2006.
Fabrazyme Side Effects Report #5484602-X
Physician from JAPAN reported FABRAZYME problem on Sept 26, 2007. Male patient, 63 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, blood pressure decreased, depressed level of consciousness. FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with DICLOFENAC, BETAMETHASONE, WARFARIN POTASSIUM, ENALAPRIL MALEATE, PRECIPITATED CALCIUM CARBONATE, MECOBALAMIN, ALFACALCIDOL. Patient recovered.
Fabrazyme Side Effects Report #5484629-8
FABRAZYME problem was reported by a Physician from JAPAN on Sept 26, 2007. Male patient, 64 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with DICLOFENAC, BETAMETHASONE, WARFARIN POTASSIUM, ENALAPRIL MALEATE, PRECIPITATED CALCIUM CARBONATE, MECOBALAMIN, ALFACALCIDOL. Patient recovered.
Fabrazyme Side Effects Report #5484630-4
Physician from JAPAN reported FABRAZYME problem on Sept 26, 2007. Male patient, 63 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with DICLOFENAC, BETAMETHASONE, ENALAPRIL MALEATE, PRECIPITATED CALCIUM CARBONATE, MECOBALAMIN, ALFACALCIDOL. Patient recovered.
Fabrazyme Side Effects Report #5484988-6
FABRAZYME problem was reported by a Physician from UNITED STATES on Oct 03, 2007. Female patient, weighting 250.0 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: disease recurrence, fatigue, malaise, peritoneal dialysis, renal failure, renal pain, stomach discomfort. FABRAZYME dosage: unknown. During the same period patient was treated with BENADRYL, TYLENOL, INCORPORATED. Patient recovered.
Fabrazyme Side Effects Report #5485654-3
Physician from DENMARK reported FABRAZYME problem on Sept 28, 2007. Male patient, 40 years of age, weighting 202.8 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: biopsy kidney abnormal, complications of transplanted kidney, renal impairment, tubulointerstitial nephritis. FABRAZYME dosage: 90 MG Q2WKS IV. During the same period patient was treated with PANTOPRAZOLE, BUMETANIZDE, PREDNISOLONE, CIPROFLOXACIN, CYCLOSPORINE, MYCOPHENOLATE MOFETIL, OXYCARBAMAZEPINE. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5487265-2
FABRAZYME problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 02, 2007. Male patient, 81 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: hernia, hypotension, pneumonia. FABRAZYME dosage: 85 MG Q2WKS IV. During the same period patient was treated with LISINOPRIL. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5487508-5
Consumer or non-health professional from BRAZIL reported FABRAZYME problem on Oct 01, 2007. Male patient, 48 years of age, weighting 110.2 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cardio-respiratory arrest, pneumonia. FABRAZYME dosage: unknown. Patient was hospitalized. Patient died on 09/28/2007.
Fabrazyme Side Effects Report #5494132-7
FABRAZYME problem was reported by a Physician from UNITED STATES on Oct 08, 2007. Male patient, 14 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: anxiety, infusion related reaction, laryngeal oedema, lip swelling, oedema mouth, pruritus, urticaria. FABRAZYME dosage: unknown. During the same period patient was treated with TYLENOL, BENADRYL. Patient recovered.
Fabrazyme Side Effects Report #5494147-9
Physician from UNITED STATES reported FABRAZYME problem on Oct 09, 2007. Male patient, 81 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: hernia, hypotension, pneumonia. FABRAZYME dosage: 85 MG Q2WKS IV. During the same period patient was treated with LISINOPRIL. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5495243-2
FABRAZYME problem was reported by a Health Professional from UNITED STATES on Oct 09, 2007. Male patient, weighting 135.0 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: abnormal behaviour, malaise. FABRAZYME dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5495511-4
Physician from FINLAND reported FABRAZYME problem on Oct 09, 2007. Female patient, 68 years of age, weighting 205.0 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: decubitus ulcer, erysipelas, intestinal obstruction, oedema peripheral, pleural effusion. FABRAZYME dosage: 105 MG Q2WKS IV. Patient died on 08/25/2007.
Fabrazyme Side Effects Report #5500124-1
FABRAZYME problem was reported by a Physician from JAPAN on Oct 15, 2007. Female patient, 61 years of age, weighting 90.39 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cardiac arrest, ventricular fibrillation. FABRAZYME dosage: 40 MG Q2WKS IV. During the same period patient was treated with VALSARTAN, CARVEDILOL. Patient died on 10/05/2007.
Fabrazyme Side Effects Report #5500125-3
Physician from ROMANIA reported FABRAZYME problem on Oct 11, 2007. Female patient, 47 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: hypoproteinaemia, oedema, proteinuria. FABRAZYME dosage: 1 MG/KG Q2WKS IV. Patient recovered.
Fabrazyme Side Effects Report #5500712-2
FABRAZYME problem was reported by a Physician from UNITED STATES on Oct 17, 2007. Male patient, 51 years of age, weighting 174.8 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: haemorrhagic stroke. FABRAZYME dosage: 105 MG Q2WKS; IV. Patient was hospitalized. Patient died on 09/26/2007.
Fabrazyme Side Effects Report #5502823-4
Consumer or non-health professional from UNITED STATES reported FABRAZYME problem on Oct 16, 2007. Male patient, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. FABRAZYME dosage: 70 MG Q2WKS IV. Patient died on 01/01/2007.
Fabrazyme Side Effects Report #5503483-9
FABRAZYME problem was reported by a Physician from FRANCE on Oct 16, 2007. Male patient, 52 years of age, weighting 149.9 lb, was diagnosed with fabry's disease, renal transplant and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: asthma, condition aggravated, haemodialysis, hypertension, renal failure, renal transplant. FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with PROGRAF, CELLCEPT. Patient recovered.
Fabrazyme Side Effects Report #5504722-0
Health Professional from FRANCE reported FABRAZYME problem on Oct 17, 2007. Male patient, 38 years of age, weighting 106.9 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: alopecia, hair colour changes, hair texture abnormal, hypersensitivity. FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with CLARITIN, ASPIRIN. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5445685-6
FABRAZYME problem was reported by a Consumer or non-health professional from UNITED STATES on Aug 24, 2007. Male patient, 46 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: renal disorder. FABRAZYME dosage: 0.5 MG/KG QWK; IV. Patient was hospitalized. Patient died on 08/22/2007.
Fabrazyme Side Effects Report #5445845-4
Physician from GERMANY reported FABRAZYME problem on Aug 21, 2007. Male patient, 41 years of age, weighting 174.2 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: anaphylactic reaction, chills, pain in extremity. FABRAZYME dosage: 70 MG/KG Q2WKS IV. During the same period patient was treated with TORSEMIDE, CANDESARTAN CILEXETIL, BISOPROLOL. Patient recovered.
Fabrazyme Side Effects Report #5445846-6
FABRAZYME problem was reported by a Health Professional from IRELAND on Aug 23, 2007. Male patient, 27 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, flushing, heart rate decreased, paraesthesia oral, sensation of heaviness, urticaria. FABRAZYME dosage: 70 MG Q2WKS IV. Patient recovered.
Fabrazyme Side Effects Report #5448202-X
Physician from JAPAN reported FABRAZYME problem on Aug 27, 2007. Female patient, 48 years of age, weighting 114.6 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: ventricular extrasystoles. FABRAZYME dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, CARVEDILOL. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5448203-1
FABRAZYME problem was reported by a Physician from JAPAN on Aug 27, 2007. Female patient, 48 years of age, weighting 114.6 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: ventricular extrasystoles. FABRAZYME dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, CARVEDILOL. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5448434-0
Physician from JAPAN reported FABRAZYME problem on Aug 27, 2007. Female patient, 48 years of age, weighting 114.6 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cardiac failure, concomitant disease aggravated, pain in extremity. FABRAZYME dosage: unknown. During the same period patient was treated with ENALAPRIL MALEATE, CARVEDILOL. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5448920-3
FABRAZYME problem was reported by a Pharmacist from UNITED STATES on Aug 24, 2007. Male patient, 73 years of age, weighting 132.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cardiac disorder. FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5449439-6
Consumer or non-health professional from AUSTRALIA reported FABRAZYME problem on Aug 31, 2007. Male patient, 52 years of age, weighting 163.1 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: anaesthetic complication cardiac, angiopathy, cardiac arrest, infarction. FABRAZYME dosage: 70 MG IV. During the same period patient was treated with METOPROLOL SUCCINATE, NITROGLYCERIN TRANSDERMAL SYSTEM, CALTRATE, PLAVIX, ALLOPURINOL, MEGAFOL, VITAMIN B6. Patient was hospitalized. Patient died on 08/17/2007.
Fabrazyme Side Effects Report #5449555-9
FABRAZYME problem was reported by a Physician from UNITED STATES on Aug 31, 2007. Male patient, 62 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cellulitis, chronic obstructive pulmonary disease, confusional state, device breakage, hypokalaemia, implantable defibrillator malfunction, ventricular tachycardia. FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with COUMADIN. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5449556-0
Consumer or non-health professional from UNITED STATES reported FABRAZYME problem on Aug 25, 2007. Female patient, 39 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: abortion spontaneous, pregnancy. FABRAZYME dosage: 1 MG/KG Q2WKS IV. Patient recovered.
Fabrazyme Side Effects Report #5449574-2
FABRAZYME problem was reported by a Health Professional from UNITED STATES on Sept 10, 2007. Female patient was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: dysphemia, feeling abnormal, hypoaesthesia, muscle twitching, tremor, vision blurred. FABRAZYME dosage: 70 MG, IV, Q 2 WKS. During the same period patient was treated with HYDROCORTISONE, BENEDRYL, KLONOPIN. Patient recovered.
Fabrazyme Side Effects Report #5452072-3
Consumer or non-health professional from UNITED STATES reported FABRAZYME problem on Aug 31, 2007. Female patient, 45 years of age, weighting 231.5 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: gallbladder disorder, gastrointestinal disorder. FABRAZYME dosage: 105 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5452109-1
FABRAZYME problem was reported by a Health Professional from UNITED STATES on Aug 31, 2007. Male patient, 46 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: blood creatinine increased, cardiac arrest, cerebral disorder, collapse of lung, convulsion, electroencephalogram abnormal, hyperkalaemia, pneumonia. FABRAZYME dosage: 35 MG QWK IV. Patient was hospitalized. Patient died.
Fabrazyme Side Effects Report #5452112-1
Consumer or non-health professional from UNITED STATES reported FABRAZYME problem on Aug 29, 2007. Male patient, 62 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: blood potassium decreased, cardiac failure congestive. FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with COUMADIN, LASIX, COREG, ZANTAC, LORTAB, KLONOPIN. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5455154-5
FABRAZYME problem was reported by a Physician from JAPAN on Sept 04, 2007. Female patient, 48 years of age, weighting 114.6 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cardiac failure, condition aggravated. FABRAZYME dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, CARVEDILOL. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5455155-7
Physician from JAPAN reported FABRAZYME problem on Sept 04, 2007. Female patient, 48 years of age, weighting 114.6 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: ventricular extrasystoles. FABRAZYME dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, CARVEDILOL. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5455157-0
FABRAZYME problem was reported by a Physician from JAPAN on Sept 04, 2007. Female patient, 48 years of age, weighting 114.6 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: ventricular extrasystoles. FABRAZYME dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with ENALAPRIL MALEATE, CARVEDILOL. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5463817-0
Physician from UNITED STATES reported FABRAZYME problem on Sept 07, 2007. Male patient, 62 years of age, was diagnosed with fabry's disease, polyuria and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: blood creatine increased, blood potassium decreased, blood urea increased, cardiac failure congestive. FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with LASIX, COUMADIN, COREG, ZANTAC, LORTAB, KLONOPIN. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5466300-1
FABRAZYME problem was reported by a Health Professional from CANADA on Sept 12, 2007. Male patient, 51 years of age, weighting 163.8 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation. FABRAZYME dosage: 75 MG Q2WKS IV. During the same period patient was treated with FLONASE, ALTACE, FOLIC ACID, METOCLOPRAMIDE, NEURONTIN, SYNTHROID. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5466301-3
Physician from JAPAN reported FABRAZYME problem on Sept 06, 2007. Male patient, 13 years of age, weighting 88.18 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cyanosis, dyspnoea. FABRAZYME dosage: 35 MG Q2WKS IV. During the same period patient was treated with HYDROXYZINE, ACETAMINOPHEN, HYDROCORTISONE SUCCINATE, CARBAMAZEPINE, PRANLUKAST HYDRATE. Patient recovered.
Fabrazyme Side Effects Report #5467038-7
FABRAZYME problem was reported by a Physician from UNITED STATES on Sept 24, 2007. Male patient, 34 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: arterial occlusive disease, foot amputation. FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with TORSEMIDE, PROGRAF, PREDNISONE, COLACE, CALCITRIOL, ZOLOFT. Patient was hospitalized and became disabled. Patient recovered.
Fabrazyme Side Effects Report #5467098-3
Consumer or non-health professional from NETHERLANDS reported FABRAZYME problem on Sept 06, 2007. Male patient, 51 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: disease progression, nuclear magnetic resonance imaging brain abnormal, oesophagitis, polyneuropathy. FABRAZYME dosage: 0.2 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5470280-2
FABRAZYME problem was reported by a Physician from UNITED STATES on Sept 11, 2007. Male patient, 73 years of age, weighting 132.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cardiac pacemaker insertion, syncope. FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with ACETAMINOPHEN. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5474885-4
Physician from JAPAN reported FABRAZYME problem on Sept 18, 2007. Male patient, 13 years of age, weighting 88.18 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cyanosis, dyspnoea, oxygen saturation decreased. FABRAZYME dosage: 35 MG Q2WKS IV. During the same period patient was treated with HYDROXYZINE, ACETAMINOPHEN, HYDROCORTISONE SUCCINATE, CARBAMAZEPINE, PRANLUKAST HYDRATE. Patient recovered.
Fabrazyme Side Effects Report #5474886-6
FABRAZYME problem was reported by a Physician from DENMARK on Sept 14, 2007. Male patient, 40 years of age, weighting 202.8 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: biopsy kidney abnormal, renal impairment. FABRAZYME dosage: 90MG Q2WKS IV. During the same period patient was treated with PANTOPRAZOL, BUMETANID, PREDNISOLONE, CIPROFLOXACIN, CYCLOSPORINE, MYCOPHENOLATMOFETIL, ACETYLSALICYLACID, OXCARBAZEPIN. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5476559-2
Health Professional from UNITED STATES reported FABRAZYME problem on Nov 09, 2006. Male patient, 32 years of age, weighting 176.4 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: chest discomfort. FABRAZYME dosage: 80 MG Q4WKS IV. During the same period patient was treated with BENADRYL, HYDROCORTISONE. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5476560-9
FABRAZYME problem was reported by a Health Professional from UNITED STATES on Nov 13, 2006. Male patient, 17 years of age, weighting 121.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: hypotension, nausea, pain, pyrexia. FABRAZYME dosage: 55 MG Q2WKS IV. During the same period patient was treated with MORPHINE, BENADRYL, CLARITIN, ZOFRAN, GABAPENTIN. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5476561-0
Health Professional from UNITED STATES reported FABRAZYME problem on Sept 15, 2006. Male patient, 51 years of age, weighting 119.0 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. FABRAZYME dosage: 55 MG Q2WKS IV. During the same period patient was treated with MOTRIN, ASPIRIN, ALBUTEROL, SINGULAIR, ATORVASTATIN CALCIUM. Patient recovered.
Fabrazyme Side Effects Report #5476562-2
FABRAZYME problem was reported by a Physician from UNITED STATES on Sept 07, 2006. Male patient, 21 years of age, weighting 132.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: paraesthesia. FABRAZYME dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5476563-4
Consumer or non-health professional from UNITED STATES reported FABRAZYME problem on Aug 14, 2006. Female patient, weighting 174.4 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: tachycardia. FABRAZYME dosage: 80 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5488162-9
FABRAZYME problem was reported by a Physician from UNITED STATES on July 24, 2007. Male patient, 46 years of age, weighting 209.4 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: heart rate decreased. FABRAZYME dosage: 3 MG/KG Q2WKS IV. Patient recovered.
Fabrazyme Side Effects Report #5488164-2
Physician from UNITED STATES reported FABRAZYME problem on July 10, 2007. Male patient, 34 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. FABRAZYME dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5488166-6
FABRAZYME problem was reported by a Physician from UNITED STATES on Apr 12, 2007. Male patient, 49 years of age, weighting 167.6 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: chest pain, chills. FABRAZYME dosage: 75 MG Q2WKS IV. During the same period patient was treated with IBUPROFEN, HYDROXYZINE. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5488167-8
Health Professional from UNITED STATES reported FABRAZYME problem on Apr 02, 2007. Female patient, 21 years of age, weighting 141.1 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cerebral infarction, dizziness, mouth haemorrhage, nausea, vertigo. FABRAZYME dosage: 1 MG/KG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5488169-1
FABRAZYME problem was reported by a Health Professional from UNITED STATES on Mar 26, 2007. Female patient, 58 years of age, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: heart rate decreased, hypotension. FABRAZYME dosage: 1 MG/KG Q2WKS IV. During the same period patient was treated with BETASERON, ALPRAZOLAM, POTASSIUM CHLORIDE, GABAPENTN, EFFEXOR, NORVASC, LISINOPRIL, TRIMETHOPRIM. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5488170-8
Physician from UNITED STATES reported FABRAZYME problem on Mar 22, 2007. Female patient, 38 years of age, weighting 135.4 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: cerebrovascular accident. FABRAZYME dosage: 70 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5488172-1
FABRAZYME problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2007. Male patient, 26 years of age, weighting 198.4 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: chills. FABRAZYME dosage: 90 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
Fabrazyme Side Effects Report #5488173-3
Health Professional from UNITED STATES reported FABRAZYME problem on Feb 07, 2007. Male patient, 41 years of age, weighting 158.7 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: blood pressure decreased, gastrointestinal disorder, urinary tract disorder. FABRAZYME dosage: 70 MG Q2WKS IV. During the same period patient was treated with ACETAMINOPHEN, HYDROXYZINE. Patient recovered.
Fabrazyme Side Effects Report #5488175-7
FABRAZYME problem was reported by a Health Professional from UNITED STATES on Dec 29, 2006. Male patient, 47 years of age, weighting 201.0 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: chest discomfort, chills, headache, pain, pyrexia. FABRAZYME dosage: 95 MG Q2WKS IV. During the same period patient was treated with ZETIA, ALLOPURINOL, LEXAPRO, WELLBUTRIN, LIPITOR. Patient was hospitalized. Patient recovered.
Showing 1-100 of 435 Next >